Overall rank by patents
#5,997
of 50,000 tracked assignees
USPTO PatentsView assignee record - 57 granted patents across 23 technology areas, recorded in grant years 2018–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA).
The verdict
According to USPTO PatentsView, Zymergen ranks #5,997 of 50,000 tracked US assignees by granted-patent volume, with 57 patents across 23 technology areas.
USPTO PatentsView assignee plate
Corpus R5997 · US Corporation #5,997 · 57 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: Elux, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Inha-industry Partne… · near
49 score
Kopin · near
49 score
Zymergen · this assignee
49 score
Autonomous Solutions · near
49 score
Rosco · near
49 score
3D Lighting Innovati… · lowest
7 score
What this shows Zymergen Inc. stamps GRANTS-SMALL, UPPER-Q, PHOTO-FINISH, CPC-FOCUS, INNOV-PAR, CLAIMS-DENSE, TYPE-USCORP, VEL-SURGE, BOOK-FULL. Volume places it #5,997 of 50,000; Innovation Score 48.9/100 sits in the top 16% of the PatentsView-derived corpus. Closest grant-volume peer on this plate is Elux, Inc. (±0 grants).
Zymergen Inc. has been granted 57 US utility patents between 2018 and 2023, placing Zymergen Inc. at #5,997 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 23 distinct Cooperative Patent Classification (CPC) subclasses, averaging 23.9 claims per patent with primary concentration in C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA). As a US Corporation, Zymergen Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Zymergen sits between Visible World, Llc (57 patents, rank #5,991) and ACM Research (shanghai), Inc. (56 patents, rank #5,999) - the closest US assignees by grant volume. The composite Innovation Score of 48.9/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Grant cadence records the difference between two grant-year windows. Between 2020 and 2024 the company received 50 grants, compared with 7 in the 2015–2019 window, a +614% shift in five-year grant velocity. Both windows cover five complete grant years; the latest PatentsView year is a partial release and is excluded from this comparison, though it still appears in the yearly table and chart below. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The US Corporation classification provides context for the assignee record, not a conclusion about its business strategy.
Claim depth and technology breadth describe this aggregate record. Zymergen Inc.'s 23.9 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 23 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Visible World, LLC
57 patents
Wargaming.net Limited
57 patents
ZF CV Systems Global GmbH
57 patents
Zhejiang Hisun Pharmaceutical Co., Ltd.
57 patents
eLux, Inc.
57 patents
eMoMo Technology Co., Ltd.
57 patents
Zymergen Inc.
57 patents
A&D COMPANY, LIMITED
56 patents
ACM RESEARCH (SHANGHAI), INC.
56 patents
What this shows Zymergen holds 57 patents at rank #5,995, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #5,995 in granted patent volume.
Other assignees with the most granted patents in Zymergen's primary technology class.
Two PlainPatent-derived peer sets for Zymergen, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (49 here).
Nearest assignees by average claims per patent (23.9 here).
Zymergen's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
49 Top 16% higher than 84% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2018 | 2 | 3.5% |
| 2019 | 5 | 8.8% |
| 2020 | 8 | 14.0% |
| 2021 | 23 | 40.4% |
| 2022 | 13 | 22.8% |
| 2023 | 6 | 10.5% |
Top 15 of 23 technology areas
Overall rank by patents
#5,997
of 50,000 tracked assignees
48.9 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.